These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18342994)

  • 21. B-natriuretic peptide in the management of heart failure.
    Armstrong J; Graber MA
    JAAPA; 2003 Jun; 16(6):35-9, 44. PubMed ID: 14968503
    [No Abstract]   [Full Text] [Related]  

  • 22. Nesiritide: trials and tribulations.
    Arora RR
    J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):165-9. PubMed ID: 17056828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is nesiritide really that good or that bad?
    Cheng TO
    Am Heart J; 2006 Apr; 151(4):e1; author reply e3. PubMed ID: 16569525
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical improvement with repeated courses of intravenous B-type natriuretic peptide in refractory heart failure.
    Spevack DM; Matros T; Shah A; Dweck E; Tunick PA
    Eur J Heart Fail; 2004 Aug; 6(5):611-3. PubMed ID: 15302009
    [No Abstract]   [Full Text] [Related]  

  • 25. Nesiritide--not verified.
    Schreiner G
    N Engl J Med; 2005 Oct; 353(14):1525-7; author reply 1525-7. PubMed ID: 16211709
    [No Abstract]   [Full Text] [Related]  

  • 26. Nesiritide as an adjunctive therapy in adult patients with heart failure undergoing high-risk cardiac surgery.
    Samuels LE; Holmes EC; Lee L
    J Thorac Cardiovasc Surg; 2004 Oct; 128(4):627-9. PubMed ID: 15457170
    [No Abstract]   [Full Text] [Related]  

  • 27. Rationale and design of the pilot randomized study of nesiritide versus dobutamine in heart failure (PRESERVD-HF).
    Gheorghiade M; Gattis WA; Adams KF; Jaffe AS; O'Connor CM; ;
    Am Heart J; 2003 Feb; 145(2 Suppl):S55-7. PubMed ID: 12594453
    [No Abstract]   [Full Text] [Related]  

  • 28. Impact of ultrafiltration on renal function in patients with decompensated heart failure.
    Kazory A; Ross EA
    Congest Heart Fail; 2009; 15(4):210-1. PubMed ID: 19627301
    [No Abstract]   [Full Text] [Related]  

  • 29. Short and long-term mortality with nesiritide.
    Arora RR; Venkatesh PK; Molnar J
    Am Heart J; 2006 Dec; 152(6):1084-90. PubMed ID: 17161057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic and therapeutic uses of natriuretic peptides. Introduction.
    Heywood JT
    Rev Cardiovasc Med; 2007; 8 Suppl 5():S1-2. PubMed ID: 18192948
    [No Abstract]   [Full Text] [Related]  

  • 31. Standardizing care for acute decompensated heart failure in a large megatrial: the approach for the Acute Studies of Clinical Effectiveness of Nesiritide in Subjects with Decompensated Heart Failure (ASCEND-HF).
    Ezekowitz JA; Hernandez AF; Starling RC; Yancy CW; Massie B; Hill JA; Krum H; Diaz R; Ponikowski P; Metra M; Howlett JG; Gennevois D; O'Connor CM; Califf RM; Fonarow GC
    Am Heart J; 2009 Feb; 157(2):219-28. PubMed ID: 19185628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacologic therapy for acute heart failure.
    Tang WH
    Cardiol Clin; 2007 Nov; 25(4):539-51; vi. PubMed ID: 18063158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nesiritide in acute heart failure.
    Burger AJ; Silver MA
    Lancet; 2003 Sep; 362(9388):998; author reply 998-9. PubMed ID: 14511939
    [No Abstract]   [Full Text] [Related]  

  • 34. Controversy and conflict in the treatment of acute decompensated heart failure: nesiritide as evidence-based treatment.
    Munger MA; Ng TM; Van Tassell BW
    Pharmacotherapy; 2007 May; 27(5):619-25. PubMed ID: 17461695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nesiritide in acute heart failure.
    Drazner M; McGuire DK; de Lemos JA
    Lancet; 2003 Sep; 362(9388):998-9. PubMed ID: 14511940
    [No Abstract]   [Full Text] [Related]  

  • 36. B-type natriuretic peptide: a treatment, not a diagnostic marker.
    Yip GW
    Heart; 2008 May; 94(5):542-4. PubMed ID: 18411344
    [No Abstract]   [Full Text] [Related]  

  • 37. Nesiritide in patients with acute myocardial infarction and heart failure: a meta-analysis.
    Zhao X; Zhang DQ; Song R; Zhang G
    J Int Med Res; 2020 Jan; 48(1):300060519897194. PubMed ID: 31948318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonhypotensive low-dose nesiritide has differential renal effects compared with standard-dose nesiritide in patients with acute decompensated heart failure and renal dysfunction.
    Riter HG; Redfield MM; Burnett JC; Chen HH
    J Am Coll Cardiol; 2006 Jun; 47(11):2334-5. PubMed ID: 16750705
    [No Abstract]   [Full Text] [Related]  

  • 39. [Usefulness of BNP in heart failure. Shortages of a current review reflect th complexity of the problem].
    Lindstedt G; Alehagen U; Dahlström U
    Lakartidningen; 2004 Feb; 101(8):688-9. PubMed ID: 15024944
    [No Abstract]   [Full Text] [Related]  

  • 40. Controversy and conflict in the treatment of acute decompensated heart failure: limited role for nesiritide.
    Noviasky JA
    Pharmacotherapy; 2007 May; 27(5):626-32. PubMed ID: 17461696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.